Immunic Inc (IMUX)

NASDAQ
2.24
+0.17(+8.21%)
After Hours
2.23
-0.01(-0.45%)
- Real-time Data
  • Volume:
    1,869,776
  • Day's Range:
    2.06 - 2.30
  • 52 wk Range:
    1.11 - 14.50

IMUX Overview

Prev. Close
2.07
Day's Range
2.06-2.3
Revenue
-
Open
2.06
52 wk Range
1.11-14.5
EPS
-2.86
Volume
1,869,776
Market Cap
99.36M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,119,992
P/E Ratio
-0.77
Beta
-
1-Year Change
-80.12%
Shares Outstanding
44,358,099
Next Earnings Date
24 Feb 2023
What is your sentiment on Immunic?
or
Market is currently closed. Voting is open during market hours.

Immunic Inc News

Immunic Inc Company Profile

Immunic Inc Company Profile

Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The Company is focused on three development programs. These include the vidofludimus calcium (IMU-838) program, which is focused on the development of oral formulations of a small molecule inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH); the IMU-935 program, which is focused on an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated (RORyt), an immune cell-specific isoform of RORy; and the IMU-856 program, which involves the development of a drug targeting the restoration of intestinal barrier function and regeneration of bowel epithelium. These product candidates are being developed to address diseases such as multiple sclerosis (MS), psoriasis and gastrointestinal diseases.

Read More

Analyst Price Target

Average21.17 (+844.94% Upside)
High39.00
Low5.00
Price2.24
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuySell
Technical IndicatorsBuyBuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell